Neuropharmacology is involved in changes of the nervous system induced by drugs and the influences of these changes, specifically within the brain. In the neuropharmacology field, people try to develop new drugs to treat neurochemical disorders, including evaluating the efficacy and safety for new potential medications. Neuropharmacology tries to understand the basic mechanism in nervous system which drugs can target to treat neurological disorders. Neuropharmacology is usually divided into two branches, containing behavioral neuropharmacology and molecular neuropharmacology. Behavioral neuropharmacology focuses on drug dependence and addictive drugs’ effects on mind. Molecular neuropharmacology focuses on the molecular level involving the study of neurons, neurotransmitters, and neuron receptors to develop new drugs.
In neuropharmacology, a number of successful pharmacokinetics-pharmacodynamics modeling efforts have been published, offering insights into detailed mechanisms of drug action in central nervous system (CNS), in spite of difficulties in the identification of proper biomarkers in CNS, limitations on clinical CNS tissue sampling, and limited understanding of CNS disease pathogenesis for neuropsychiatric and neurodegenerative diseases. Creative Biomart can provide recombinant proteins tools for neuropharmacology research applications.
1. Cooper J R, Bloom F E, Roth R H. The biochemical basis of neuropharmacology[M]. Oxford University Press, 2003.
2. Nestler E J, Hyman S E, Malenka R C. Molecular neuropharmacology: a foundation for clinical neuroscience[M]. McGraw-Hill Medical, 2001.